罗曼;薛月珍;汪佩馨;陶文琪;

• 1:上海交通大学附属第六人民医院妇产科
• 2:上海交通大学附属第六人民医院病理科

摘要：

目的评估新柏氏膜式液基超薄细胞学检测(TCT)报告中不能明确诊断的不典型鳞状及腺上皮细胞的意义,为临床确定不典型鳞状和腺上皮细胞的诊断提供依据。方法搜集15188例TCT标本中的131例ASC-US、ASC-H及AGC患者情况,对其中78例有明确病理诊断的标本进行回顾性分析。结果ASC-US患者中有55.9%为CINⅠ级和SPI改变,40.7%为良性反应性改变,3.4%为CINⅡ～Ⅲ级,浸润癌为0;ASC-H中77.8%为女性生殖道浸润癌,11.1%为CINⅠ级和SPI改变,另11.1%为CINⅡ～Ⅲ级;AGC中良性改变占20%,CINⅠ级和SPI改变、宫内膜不规则增生各占30%,CINⅡ～Ⅲ级与癌症各占10%。结论对于TCT筛查中出现的ASC-US、ASC-H及AGC要采取不同的随访及检查手段,以明确最后诊断,防止漏诊或过度治疗。

关键词： 宫颈肿瘤;病理学,临床;筛查

Abstract: Objective To evaluate the significance of undermining atypical cells of TCT screening reports,and to give guidance to clinic doctors in order to use various ways to determine their pathologic diagnosis.Methods 131 ASC-US,ASC-H,AGC patients were selected from 15 188 TCT reports,and gave retrospective study in 78 patients of which who have straightforward pathologic diagnosis were given retrospective study.Results Out of 59 ASC-US patients,55.9% patients are diagnosed of CINⅠor SPI,40.7% of them are classified as normal or reactive action;3.4% of them are diagnosed by biopsy of CIN Ⅱ～Ⅲ;None of them are malignant.Out of 9 ASC-H patients,group CINⅠor SPI and group CIN Ⅱ～Ⅲ only have 1 patient respectively(11.1%),but most of them are diagnosed of carcinomas(77.8%).Among 10 AGC patients,2 patients are benign lesion(20%);3 people are included in group CINⅠor SPI and group endometrial irregular hyperplasia(30%) respectively;group CIN Ⅱ～Ⅲ and group carcinoma has only 1 people respectively(10%).Conclusion The ASC-US,ASC-H and AGC patients selected from TCT screening need a final diagnosis by various ways.

Keywords: Cervical neoplasms;Pathology,clinic;Screening

基金项目:

通讯作者:

Email:

参考文献：

• 1Gerbera S,De Grandia P,Petignata P,et al.Colposcopic evaluation after a repeat atypical squamous cells of undetermined significance(ASC-US)smear.IJGO,2001,40:251-255.
• 2Lee KR,Ashfaq R,Birdsong GG,et al.Comparison of conventional Papanicolaou smears and afluid-based,thin-layer systemfor cervical cancer screening.Obstet Gynecol,1997,90:278-284.
• 3Flynn K,Ri mm DL.Diagnosis of“ASCUS”in women over age50is less likely to be associated with dysplasia.Diagn Cytopathol,2001,24:132-136.
• 4Lousuebsakul V,Knutsen SM,Gram IT,et al.Clinical i mpact of atypical squamous cells of undetermined significance.Acytohisto-logic comparison.Acta Cytol,2000,44:23-30.
• 5Sherman ME,Solomon D,Schiffman M,et al.Qualification of AS-CUS.Acomparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study.Am J Clin Pathol,2001,116:386-394.
• 6DeSi mone CP,Day ME,Tovar MM,et al.Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda2001nomenclature.Obstet Gynecol,2006,107:1285-1291.
• 7Moore K,Cofer A,Elliot L,et al.Adolescent cervical dysplasia:his-tologic evaluation,treatment,and outcomes.Am J Obstet Gy-necol,2007,197:141.